Paper8515422
Hypoxia-selective antitumor agents. 7. Metal complexes of aliphatic mustards as a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards.
Ware DC and 3 others. J Med Chem, 1993. Cited by 112 papers, by iCite.
Cite this record
ConductScience Library. Hypoxia-selective antitumor agents. 7. Metal complexes of aliphatic mustards as a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards. Papers, record 8515422. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8515422
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hypoxia-selective antitumor agents. 7. Metal complexes of aliphatic mustards as a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Cobalt | Major topic |
| Nitrogen Mustard Compounds | Major topic |
| Animals | |
| CHO Cells | |
| Cell Hypoxia | |
| Cricetinae | |
| Cricetulus | |
| Drug Screening Assays, Antitumor | |
| Oxidation-Reduction | |
| Structure-Activity Relationship |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 112 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42432465 | Medicinal Chemistry of Agents for Cancer Therapy and Diagnosis From Uruguay. | ChemMedChem | 2026 | https://conductscience.org/library/papers/42432465 | PubMed |
| 41574478 | Tumor-Selective and Chemical Activation Strategies for Nitrogen Mustard Prodrugs. | Chemistry | 2026 | https://conductscience.org/library/papers/41574478 | PubMed |
| 34046181 | Development of a cobalt(iii)-based ponatinib prodrug system. | Inorg Chem Front | 2021 | https://conductscience.org/library/papers/34046181 | PubMed |
| 33222438 | Improving the Stability of EGFR Inhibitor Cobalt(III) Prodrugs. | Inorg Chem | 2020 | https://conductscience.org/library/papers/33222438 | PubMed |
| 30672949 | Physical properties, ligand substitution reactions, and biological activity of Co(iii)-Schiff base complexes. | Dalton Trans | 2019 | https://conductscience.org/library/papers/30672949 | PubMed |
| 30575832 | Hypoxia-targeted drug delivery. | Chem Soc Rev | 2019 | https://conductscience.org/library/papers/30575832 | PubMed |
| 29259746 | Synthesis and Evaluation of Radiolabeled Phosphoramide Mustard with Selectivity for Hypoxic Cancer Cells. | ACS Med Chem Lett | 2017 | https://conductscience.org/library/papers/29259746 | PubMed |
| 27143654 | Hypoxic tumor microenvironment: Opportunities to develop targeted therapies. | Biotechnol Adv | 2016 | https://conductscience.org/library/papers/27143654 | PubMed |
| 25079700 | Tumor-targeting of EGFR inhibitors by hypoxia-mediated activation. | Angew Chem Int Ed Engl | 2014 | https://conductscience.org/library/papers/25079700 | PubMed |
| 23845143 | Bioreductive prodrugs as cancer therapeutics: targeting tumor hypoxia. | Chin J Cancer | 2014 | https://conductscience.org/library/papers/23845143 | PubMed |
| 23001051 | Synthesis, characterization, and antibacterial and anticancer screening of {M(2+)-Co (3+)-M (2+)} and {Co (3+)-M (2+)} (M is Zn, Cd, Hg) heterometallic complexes. | J Biol Inorg Chem | 2012 | https://conductscience.org/library/papers/23001051 | PubMed |
| 22289471 | Redox activation of metal-based prodrugs as a strategy for drug delivery. | Adv Drug Deliv Rev | 2012 | https://conductscience.org/library/papers/22289471 | PubMed |
| 21606941 | Targeting hypoxia in cancer therapy. | Nat Rev Cancer | 2011 | https://conductscience.org/library/papers/21606941 | PubMed |
| 21275772 | Anticancer activity of metal complexes: involvement of redox processes. | Antioxid Redox Signal | 2011 | https://conductscience.org/library/papers/21275772 | PubMed |
| 19772288 | In situ imaging of metals in cells and tissues. | Chem Rev | 2009 | https://conductscience.org/library/papers/19772288 | PubMed |
| 18418632 | Cellular uptake and distribution of cobalt complexes of fluorescent ligands. | J Biol Inorg Chem | 2008 | https://conductscience.org/library/papers/18418632 | PubMed |
| 10815768 | Cyclophosphamides as hypoxia-activated diffusible cytotoxins: a theoretical study. | J Comput Aided Mol Des | 2000 | https://conductscience.org/library/papers/10815768 | PubMed |
| 8763845 | Pulse radiolysis studies on the hypoxia-selective toxicity of a colbalt-mustard complex. | Br J Cancer Suppl | 1996 | https://conductscience.org/library/papers/8763845 | PubMed |
| 8763842 | Recent developments in the design of bioreductive drugs. | Br J Cancer Suppl | 1996 | https://conductscience.org/library/papers/8763842 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8515422
GET https://conductscience.org/api/papers/v1/8515422/authors